Alabama's ALL Kids Program Enables Access to Groundbreaking Gene Therapy
The Alabama Department of Public Health has enabled a child to receive Otarmeni™, the first FDA-approved gene therapy for genetic hearing loss. This initiative expands opportunities for healthcare providers and contractors specializing in gene therapy and pediatric care, highlighting the need for service infrastructure and procurement strategies to support innovative treatments.